The trading price of Protagonist Therapeutics Inc (NASDAQ:PTGX) floating higher at last check on current market day and closing at $47.70, 5.93% higher than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $44.97
Protagonist Therapeutics Inc (NASDAQ:PTGX) traded at $48.36 at close of the session on Monday, March 31 and made a downward move of -1.06% on its previous day’s price. Looking at the stock we see that its previous close was $48.88 and the beta (5Y monthly)
The trading price of Protagonist Therapeutics Inc (NASDAQ:PTGX) closed lower on current market day and closing at $52.53, -0.23% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $51.61 and $53.7. The company’s P/E
Protagonist Therapeutics Inc (NASDAQ:PTGX) price closed lower on Monday, March 17, and dropping -3.23% below its previous close. A look at the daily price movement shows that the last close reads $54.78, with intraday deals fluctuated between $52.26 and $54.25. The company’s 5Y monthly beta
Protagonist Therapeutics Inc (NASDAQ:PTGX) concluded the trading at $54.90 on Thursday, March 13 with a fall of -4.77% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $57.65 and 5Y monthly beta
Protagonist Therapeutics Inc (NASDAQ:PTGX) traded at $55.95 at close of the session on Monday, March 10 and made an upward move of 45.89% on its previous day’s price. Protagonist Therapeutics Inc has a market cap of $3.43 billion and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
